Astellas Pharma Inc
Clinical trials sponsored by Astellas Pharma Inc, explained in plain language.
-
Massive study launched to track safety of arthritis drug in real patients
Disease control Recruiting nowThis study aims to monitor the safety and effectiveness of the drug peficitinib for rheumatoid arthritis in real-world clinical practice in Japan. It will enroll 3,000 patients who are starting treatment with peficitinib for the first time. The main goal is to collect information…
Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Monthly eye jabs tested to slow blinding disease
Disease control Recruiting nowThis study is checking the safety of a drug called ASP3021 for people in Japan with geographic atrophy, a condition that causes gradual, permanent vision loss. About 20 participants will receive a monthly injection of the drug directly into their affected eye for one year. The ma…
Phase: PHASE4 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
First-in-Human trial targets common Cancer-Causing gene
Disease control Recruiting nowThis is the first time researchers are giving the experimental drug ASP5834 to people. The study aims to find a safe dose and check for side effects in adults with advanced solid tumors that have specific changes in a gene called KRAS. Some participants with colorectal cancer wil…
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New drug targets 'Undruggable' cancer mutation in first human trial
Disease control Recruiting nowThis is a first-in-human study to find a safe dose of a new drug, ASP3082, for people with advanced solid tumors that have a specific genetic change called KRAS G12D. The study will test ASP3082 alone and in combination with other cancer drugs in up to 681 participants. The main …
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC